2666-5344

Biomaterials and Biosystems

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 124 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact124 DOIs
2

Attach ORCID iDs across 38 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact38 DOIs
3

Deposit reference lists for 10 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact10 DOIs

DOIs for this ISSN

Showing the top 5 of 124 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Collagen type II: From biosynthesis to advanced biomaterials… (10.1016/j.bbiosy.2021.100030)
Abstract ORCID
82.17 43
2 Current good manufacturing practice considerations for mesen… (10.1016/j.bbiosy.2021.100018)
Abstract ORCID
77.82 35
3 Advanced non-fluoride approaches to dental enamel reminerali… (10.1016/j.bbiosy.2021.100029)
Abstract ORCID
77.82 35
4 Mitochondria-targeted nanoparticles (mitoNANO): An emerging… (10.1016/j.bbiosy.2021.100023)
Abstract ORCID
77.20 34
5 A review of strategies for development of tissue engineered… (10.1016/j.bbiosy.2021.100026)
Abstract ORCID
68.09 22
6 Setup of human liver-chips integrating 3D models, microwells… (10.1016/j.bbiosy.2022.100054)
Abstract ORCID
63.94 18
7 Electrospun decellularized extracellular matrix scaffolds pr… (10.1016/j.bbiosy.2023.100081)
Abstract ORCID
63.94 18
8 Proof-of-concept trial of an amniotic fluid-derived extracel… (10.1016/j.bbiosy.2021.100031)
Abstract ORCID
62.76 17
9 Amorphous calcium phosphate, the lack of order is an abundan… (10.1016/j.bbiosy.2021.100037)
Abstract ORCID
61.52 16
10 Chemical modification strategies to prepare advanced protein… (10.1016/j.bbiosy.2021.100010)
Abstract ORCID
55.70 12
11 Biodegradable nanoparticulate co-delivery of flavonoid and d… (10.1016/j.bbiosy.2021.100022)
Abstract ORCID
53.96 11
12 The role of inflammatory mediators and matrix metalloprotein… (10.1016/j.bbiosy.2024.100090)
Abstract
53.18 133
13 Development of decellularization protocol for caprine small… (10.1016/j.bbiosy.2021.100035)
Abstract ORCID
52.07 10
14 Electrochemical and in vitro biological behaviors of a Ti-Mo… (10.1016/j.bbiosy.2023.100076)
Abstract ORCID
50.00 9
15 Biomaterials functionalized with magnetic nanoparticles for… (10.1016/j.bbiosy.2024.100100)
Abstract ORCID
50.00 9
16 Granular hydrogels for endogenous tissue repair (10.1016/j.bbiosy.2021.100008)
Abstract
48.36 85
17 Magnetic CuFe2O4 with intrinsic protease-like activity inhib… (10.1016/j.bbiosy.2021.100038)
Abstract ORCID
47.71 8
18 Comparison of human amniotic membrane and collagen nerve wra… (10.1016/j.bbiosy.2022.100048)
Abstract ORCID
47.71 8
19 Polymeric siRNA delivery targeting integrin-β1 could reduce… (10.1016/j.bbiosy.2021.100021)
Abstract ORCID
45.15 7
20 Spacer length and serum protein adsorption affect active tar… (10.1016/j.bbiosy.2021.100032)
Abstract ORCID
45.15 7
21 The role of extracellular matrix in angiogenesis: Beyond adh… (10.1016/j.bbiosy.2024.100097)
Abstract
40.58 41
22 Evaluation of a co-culture of rapidly isolated chondrocytes… (10.1016/j.bbiosy.2022.100066)
Abstract ORCID
38.91 5
23 3D printed hybrid scaffolds do not induce adverse inflammati… (10.1016/j.bbiosy.2024.100087)
Abstract ORCID
34.95 4
24 Current interpretations on the in vivo response of bone to a… (10.1016/j.bbiosy.2021.100013)
Abstract
34.51 23
25 Design considerations of benchtop fluid flow bioreactors for… (10.1016/j.bbiosy.2022.100063)
Abstract
34.04 22
26 Immunomodulatory nanosystems: An emerging strategy to combat… (10.1016/j.bbiosy.2023.100073)
Abstract
34.04 22
27 Rise of tissue- and species-specific 3D bioprinting based on… (10.1016/j.bbiosy.2023.100084)
Abstract
33.56 21
28 Natural language processing in toxicology: Delineating adver… (10.1016/j.bbiosy.2022.100061)
Abstract
32.53 19
29 Tissue engineering and regenerative medicine strategies for… (10.1016/j.bbiosy.2022.100046)
Abstract
31.97 18
30 The convergence of high-tech emerging technologies into the… (10.1016/j.bbiosy.2021.100012)
Abstract
30.76 16
31 Endothelial barrier function is co-regulated at vessel bifur… (10.1016/j.bbiosy.2021.100020)
Abstract ORCID
30.10 3
32 Embracing complexity in biomaterials design (10.1016/j.bbiosy.2022.100039)
Abstract
29.40 14
33 Mesenchymal stromal cell exosomes enhance dental pulp cell f… (10.1016/j.bbiosy.2023.100078)
Abstract
29.40 14
34 Growth factor and macromolecular crowding supplementation in… (10.1016/j.bbiosy.2021.100009)
Abstract
27.85 12
35 Engineered extracellular vesicles antagonize SARS-CoV-2 infe… (10.1016/j.bbiosy.2022.100042)
Abstract
26.98 11
36 Advancements in nanomedicines for the detection and treatmen… (10.1016/j.bbiosy.2022.100047)
Abstract
26.98 11
37 Polycaprolactone-collagen nanofibers loaded with dexamethaso… (10.1016/j.bbiosy.2022.100064)
Abstract
26.03 10
38 3D printed bioabsorbable composite scaffolds of poly (lactic… (10.1016/j.bbiosy.2023.100086)
Abstract
26.03 10
39 Third body damage and wear in arthroplasty bearing materials… (10.1016/j.bbiosy.2021.100028)
Abstract
25.00 9
40 Antimicrobial-free graphene nanocoating decreases fungal yea… (10.1016/j.bbiosy.2022.100069)
Abstract
25.00 9
41 Optimization and evaluation of oxygen-plasma-modified, align… (10.1016/j.bbiosy.2023.100083)
Abstract
25.00 9
42 Cell engineering techniques improve pharmacology of cellular… (10.1016/j.bbiosy.2021.100016)
Abstract ORCID
23.86 2
43 Bioabsorbable metal zinc differentially affects mitochondria… (10.1016/j.bbiosy.2021.100027)
Abstract ORCID
23.86 2
44 Biomaterials enhancing performance of cell and nucleic-acid… (10.1016/j.bbiosy.2021.100036)
Abstract ORCID
23.86 2
45 Bioactive engineered scaffolds based on PCL-PEG-PCL and tumo… (10.1016/j.bbiosy.2022.100055)
Abstract
23.86 8
46 A quest for cytocompatible metal organic frameworks in non-v… (10.1016/j.bbiosy.2022.100065)
Abstract
23.86 8
47 Embracing simplicity in biomaterials design (10.1016/j.bbiosy.2022.100043)
Abstract
22.58 7
48 Concentrated autologous bone marrow aspirate is not “stem ce… (10.1016/j.bbiosy.2021.100017)
Abstract
21.13 6
49 Application of bioengineered elastin-like polypeptide-based… (10.1016/j.bbiosy.2022.100050)
Abstract
21.13 6
50 Mechanoregulated trabecular bone adaptation: Progress report… (10.1016/j.bbiosy.2022.100058)
Abstract
21.13 6